O
OrbiMed’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,512,866
| Closed | -$22.8M | – | 117 |
|
|
2024
Q2 | $22.8M | Sell |
6,512,866
-3,598,684
| -36% | -$12.6M | 0.45% | 57 |
|
|
2024
Q1 | $28M | Buy |
10,111,550
+4,182,959
| +71% | +$11.6M | 0.51% | 53 |
|
|
2023
Q4 | $10.1M | Buy |
5,928,591
+5,125,891
| +639% | +$8.71M | 0.2% | 76 |
|
|
2023
Q3 | $827K | Hold |
802,700
| – | – | 0.02% | 114 |
|
|
2023
Q2 | $931K | Hold |
802,700
| – | – | 0.02% | 116 |
|
|
2023
Q1 | $1.21M | Buy |
+802,700
| New | +$1.21M | 0.02% | 110 |
|
|
2022
Q4 | – | Sell |
-1,123,000
| Closed | -$4.74K | – | 121 |
|
|
2022
Q3 | $4.74K | Buy |
+1,123,000
| New | +$4.74K | 0.09% | 104 |
|
|
2021
Q1 | – | Sell |
-1,191,846
| Closed | -$25.2M | – | 167 |
|
|
2020
Q4 | $25.2M | Hold |
1,191,846
| – | – | 0.22% | 91 |
|
|
2020
Q3 | $17.7M | Buy |
1,191,846
+531,426
| +80% | +$7.88M | 0.22% | 88 |
|
|
2020
Q2 | $9.72M | Buy |
660,420
+123,000
| +23% | +$1.81M | 0.14% | 100 |
|
|
2020
Q1 | $6.31M | Buy |
+537,420
| New | +$6.31M | 0.11% | 94 |
|
|
2019
Q2 | – | Sell |
-1,069,000
| Closed | -$26.1M | – | 123 |
|
|
2019
Q1 | $26.1M | Sell |
1,069,000
-331,300
| -24% | -$8.1M | 0.4% | 61 |
|
|
2018
Q4 | $36.3M | Sell |
1,400,300
-114,200
| -8% | -$2.96M | 0.67% | 47 |
|
|
2018
Q3 | $47.9M | Buy |
1,514,500
+199,400
| +15% | +$6.31M | 0.58% | 55 |
|
|
2018
Q2 | $51.1M | Buy |
1,315,100
+175,300
| +15% | +$6.81M | 0.61% | 50 |
|
|
2018
Q1 | $31.5M | Buy |
1,139,800
+489,800
| +75% | +$13.5M | 0.39% | 66 |
|
|
2017
Q4 | $11.8M | Hold |
650,000
| – | – | 0.15% | 100 |
|
|
2017
Q3 | $10.5M | Hold |
650,000
| – | – | 0.1% | 104 |
|
|
2017
Q2 | $9M | Hold |
650,000
| – | – | 0.09% | 98 |
|
|
2017
Q1 | $9.75M | Buy |
+650,000
| New | +$9.75M | 0.11% | 97 |
|